Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium

@article{Nobili2011MultipleDA,
  title={Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium},
  author={Alessandro Nobili and Silvio Ken Garattini and Pier Mannuccio Mannucci},
  journal={Journal of Comorbidity},
  year={2011},
  volume={1},
  pages={28 - 44}
}
The pattern of patients admitted to internal medicine wards has dramatically changed in the last 20–30 years. Elderly people are now the most rapidly growing proportion of the patient population in the majority of Western countries, and aging seldom comes alone, often being accompanied by chronic diseases, comorbidity, disability, frailty, and social isolation. Multiple diseases and multimorbidity inevitably lead to the use of multiple drugs, a condition known as polypharmacy. Over the last 20… Expand
An Overview of Polypharmacy in Geriatric Patients
TLDR
Effective communication between the pharmacists and the patient and reasonable intervention by the pharmacist could prevent the negative effects caused by medica‐ tions, and an ethical perspective is crucial for considering geriatric patients’ benefit. Expand
Chapter 4 An Overview of Polypharmacy in Geriatric Patients
Ageing causes a decrease in cognitive and physical abilities, thus making the elderly more sensitive and vulnerable. Besides, the elderly’ living conidtions are greatly affected by various diseasesExpand
Internal and geriatric medicine: an alliance for the challenges of the elderly.
TLDR
There is a need to shift towards a patient-oriented model, where diagnosis and treatment of diseases should be incorporated in a multidimensional evaluation that explores comorbidity, nutritional, functional, cognitive, psychological and socioeconomic domains and provides clinicians with a global view of the patients' needs. Expand
Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future
TLDR
Long-term prescription-medicine use and the prevalence of polypharmacy in the elderly in the Republic of Srpska were analyzed and the findings were used to suggest potential future measures. Expand
Evidence-Based Versus Evidence-Biased Medicine in Geriatric Cardiology: From Trials to Real World
TLDR
The lack of well-designed clinical studies recruiting elderly limits the availability of evidence-based information on the effect of drugs on clinically relevant outcomes such as functional and cognitive decline, quality of life, adverse events, and mortality. Expand
Effect of Polypharmacy in Geriatrics Population – A Pharmacovigilance Study
As per the census of 2001 geriatric population accounts for 7.4% of total population which increases to 8.2% by 2011 and likely to be 10.7% by 2021. Aging is associated with decreased renal andExpand
POLYPHARMACY IN ELDERLY PATIENTS AND THEIR PROBLEMS
TLDR
The effect of polypharmacy in elderly patients is described and the possibility of getting more number of drugs consequently has the potential to improve prescribing patterns that are not appropriate and contribute to ADRs and hospitalizations. Expand
The primary assessment of prescribing drugs for the elderly people conducted by pharmacists
TLDR
Based on the data analyzed, the current issues associated with drug therapy, dosing, drug-drug interactions, and side effects have been determined; the practical recommendations for pharmacists related to the treatment advice given to this group of patients have been proposed. Expand
The Double Burden of the COVID-19 Pandemic and Polypharmacy on Geriatric Population – Public Health Implications
TLDR
This review explains the public health implications associated with polypharmacy on the geriatric population with pre-existing co-morbidities during the COVID-19 pandemic and how adherence to the guidelines and recommendations of WHO, CDC, and other national/regional/international agencies can reduce the risks of SARS-CoV-2 infection. Expand
Geriatric syndromes: How to treat
TLDR
Possible strategies to face the increasingly prevalent geriatric syndromes in HIV-infected persons are discussed and the importance of shifting from the traditional disease-oriented approach into models of care facilitating a multidisciplinary management of frailty is explained. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 177 REFERENCES
Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy.
TLDR
It is feasible to decrease medication burden in community-dwelling elderly patients and this tool would be suitable for larger randomized controlled trials in different clinical settings. Expand
Polypharmacy and falls in the middle age and elderly population.
TLDR
Fall risk is associated with the use of polypharmacy, but only when at least one established fall risk-increasing drug was part of the daily regimen. Expand
Polypharmacy in elderly hospitalised patients in Slovakia
TLDR
A relatively high prevalence of polypharmacy in Slovak elderly patients was confirmed, especially with the increased prevalence of diseases of advancing age (diabetes mellitus, heart failure, arterial hypertension, dementia and cerebrovascular diseases). Expand
Polypharmacy in elderly patients.
TLDR
It is found that polypharmacy continues to increase and is a known risk factor for important morbidity and mortality, and health care professionals should be aware of the risks and fully evaluate all medications at each patient visit to prevent polypharacy from occurring. Expand
Optimising drug treatment for elderly people: the prescribing cascade
TLDR
This article will focus on an under-recognised, and largely preventable drug related problem that is termed the “prescribing cascade”, which is an important area to target both to improve the quality of medical care for elderly people and to reduce the costs of health care for this population. Expand
Potentially inappropriate medications in geriatric outpatients with polypharmacy: application of six sets of published explicit criteria.
TLDR
Caution should be exercised in applying PIM criteria developed in other regions when medication availability in the local market is limited, as the prevalence of PIM varied significantly when different criteria were applied. Expand
Polypharmacy Status as an Indicator of Mortality in an Elderly Population
TLDR
This study points to the importance of excessive polypharmacy as an indicator for mortality in elderly persons following adjustment for co-morbidities. Expand
Quality Indicators for Medication Use in Vulnerable Elders
TLDR
This updated set of QIs reevaluates QIs to assess pharmacological care provided to community-dwelling VEs and finds substantial underuse of appropriate medications and shortfalls were seen in medication monitoring and education. Expand
Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender
TLDR
Age and gender may not be as important as number of drugs prescribed as predictors of experiencing a DRP among patients with polypharmacy, and a similar trend was observed in the development of ADRs. Expand
Methodological issues in pharmacotherapy research in older adults.
TLDR
This commentary discusses the common challenges of research on pharmacotherapy in older adults and provides strategies to overcome such challenges, and encourages researchers and clinicians to foster more studies that critically evaluate pharmacotherapy and medication-management services and maximizing treatment outcomes in Older adults. Expand
...
1
2
3
4
5
...